Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.
In ₹ Crore except Per Share Latest Annual | ANUHPHR FY26 | AHCL FY26 | WANBURY FY25 | ZIMLAB FY26 | Peer Average | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | 19.42× | ◆ 4.00× | 18.69× | 118.71× | 47.13× -59% | |
| P/B | 2.27× | ◆ 0.56× | 9.63× | 2.55× | 4.25× -47% | |
| EV/EBITDA | 12.07× | ◆ 4.08× | 9.58× | 27.83× | 13.83× -13% | |
| Market Cap | ₹798 Cr | ₹130 Cr | ₹571 Cr | ₹756 Cr | ₹486 Cr +64% | |
| Growth | ||||||
| Revenue CAGR 3Y | — | — | ◆ 5.46% | -2.06% | 1.70% | |
| Revenue CAGR 5Y | — | — | 10.29% | — | 10.29% | |
| Net Income CAGR 3Y | — | — | ◆ -27.91% | -37.95% | -32.93% | |
| Revenue YoY (latest Q) | 3.93% | — | 24.47% | ◆ 31.25% | 27.86% -86% | |
| Net Income YoY (latest Q) | 37.63% | — | ◆ 1200.41% | -114.25% | 543.08% -93% | |
| Profitability | ||||||
| EBITDA Margin | 8.00% | ◆ 27.63% | 12.73% | 8.02% | 16.13% -50% | |
| Net Income Margin | 5.32% | ◆ 16.92% | 5.09% | 1.56% | 7.86% -32% | |
| Return on Common Equity | 12.10% | 12.38% | ◆ 70.01% | 2.13% | 28.17% -57% | |
| Return on Capital Employed | 14.75% | 17.26% | ◆ 34.18% | 3.06% | 18.17% -19% | |
| Return on Assets | 7.72% | 7.78% | ◆ 8.06% | 1.15% | 5.66% +36% | |
| Credit & Quality | ||||||
| Total Debt/Equity | ◆ 0.00× | 0.17× | 2.92× | 0.42× | 1.17× -100% | |
| Interest Coverage | ◆ 106.58× | 12.30× | 1.71× | 0.76× | 4.92× +2065% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹772 Cr | ₹172 Cr | ₹600 Cr | ₹374 Cr | ₹382 Cr +102% | |
| Net Income | ₹41 Cr | ₹29.1 Cr | ₹30.5 Cr | ₹5.8 Cr | ₹21.8 Cr +88% | |
| Total Assets | ₹557 Cr | ₹374 Cr | ₹414 Cr | ₹539 Cr | ₹442 Cr +26% | |
| EPS | ₹4.1 | ₹6.11 | ₹9.32 | ₹1.19 | ₹5.54 -26% | |
| Book Value per Share | ₹35.14 | ₹43.32 | ₹18.09 | ₹55.36 | ₹38.92 -10% | |